Taiko Pharmaceutical Co.,Ltd. provided earnings guidance for the quarter end December 2021. For the quarter, the company expects Net sales to be JPY 22,000 million. Operating profit to be JPY 4,500 million. Profit attributable to owners of parent to be JPY 3,100 million. Basic earnings per share to be JPY 71.57.